Randomized phase III trial of paclitaxel/carboplatin with or without PF-3512676 (toll-like receptor 9 agonist) as first-line treatment for advanced non-small-cell lung cancer

Vera Hirsh, Luis Paz-Ares, Michael Boyer, Rafael Rosell, Gary Middleton, Wilfried E.E. Eberhardt, Aleksandra Szczesna, Pavel Reiterer, Mansoor Saleh, Oscar Arrieta, Emilio Bajetta, Roy T. Webb, Johannes Raats, Rebecca J. Benner, Camilla Fowst, Sandra J. Meech, David Readett, Joan H. Schiller

Research output: Contribution to journal › Article › peer-review

126 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Randomized phase III trial of paclitaxel/carboplatin with or without PF-3512676 (toll-like receptor 9 agonist) as first-line treatment for advanced non-small-cell lung cancer'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science